Company intelligence / Profile preview

Iris Biotech GmbH

Marktredwitz, Bavaria, Germanyiris-biotech.de ↗

Ownership: Private
Development stage: Commercial

Overview

Iris Biotech does not conduct clinical trials or report clinical results. They supply high-quality compounds—especially peptides/building blocks/linkers/reagents—for life science R&D and manufacturing worldwide.

Their custom synthesis service enables access to novel or rare compounds at scales from milligrams to kilograms.

The company’s expertise supports academic labs as well as pharmaceutical/biotechnology industry clients from early discovery through commercial production.

No pipeline of therapeutic programs.

Products are widely used in the development of drugs/vaccines targeting major diseases including cancer and neurodegeneration.

They have built a reputation for quality control and customer support.

"Empowering Peptide Innovation" summarizes their mission.

Therapeutic areas: OncologyEndocrinologyNeurologyInfectious Diseases
Modalities: Peptides and peptide building blocks (amino acids, derivatives)Small molecules (reagents, linkers, substrates, inhibitors)Polymers for drug delivery (PEGs, poly(2-oxazolines), etc.)Resins for solid phase synthesis
Industry: Chemicals & Materials

Partnerships

Peptide Solutions LLC (US distributor)Chengdu Yoo Technology Co., Ltd. (China distributor)BizCom Japan Inc., Shigematsu & Co., Ltd., Cosmo Bio Co., Ltd. (Japan distributors)Sumit Biosciences Pvt Ltd. (India/Bangladesh/Oman/Sri Lanka/UAE distributor)

Beyond the preview

Go deeper on Iris Biotech GmbH.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Iris Biotech GmbH.

Explore the full profile